JM

James McBrayer

Cyclopharm Limited | Chief Executive Officer, Managing Director, Company Secretary
Mr McBrayer has more than 35 years of experience in nuclear medicine, healthcare manufacturing, and regulated pharmaceutical businesses. Prior to Cyclopharm, Mr McBrayer was Managing Director of Lipa Pharmaceuticals, a contract manufacturer of over-the-counter healthcare products, where he led large-scale manufacturing, supply-chain, and regulatory operations serving domestic and international brands. Earlier in his career, he held senior management roles with Brambles Cleanaway, gaining experience in complex, asset-heavy service businesses, and with Syncor a provider of radioactive diagnostic and therapeutic pharmaceuticals, where he developed expertise in nuclear medicine logistics, regulatory compliance, and building global healthcare operations to include start-ups. He is a member of the Board Nominations Committee.

Company and Roles

Company
Title
Tenure
Since
CYC
Cyclopharm Limited
  • Chief Executive Officer
  • Managing Director
  • Company Secretary
18yrs, 1mthJun 2008

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CYC
Cyclopharm Limited
12/03/262,473,5072,846,5990N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CYC
Cyclopharm Limited
12/03/26
Buy
10,526$0.950$9,999Participation in share purchase plan
CYC
Cyclopharm Limited
30/11/23
Buy
200,000$1.310$262,000Exercise of options
CYC
Cyclopharm Limited
30/11/23
Exercise
200,000$1.310$262,000Exercise of options
CYC
Cyclopharm Limited
24/07/20
Issued
1,015,500$1.410$1,431,855Issue of securities
CYC
Cyclopharm Limited
11/12/19
Issued
539,525$1.050$566,501Issue of securities